HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Affinity Detection and Quantification of Receptors of TRAIL Based on Their Thermostability].

AbstractOBJECTIVE:
To develop a way for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors quantification in cancer via its' thermostability.
METHODS:
Endougenous alkaline phosphatase (AP) activity and denaturation temperature of pancreatic cancer cell lines AsPC-1 and Capan-2 were detected. Boiling treated recombinant protein death receptor 5 (DR5), named DR5 AP, as well as pancreatic cancer cells lines AsPC-1 and Capan-2 were incubated with AP-tagged TRAIL (AP-TRAIL), and then reacted with Reagent A and Reagent S, the substrate of AP, to quantitive and in site detection of the receptor.
RESULTS:
The endougenous AP activity of pancreatic cancer cells lines AsPC-1 and Capan-2 could not be totally inactivated by incubated at 65 °C, thus inhibited the detection of TRAIL receptor, but the activity was dramatically decreased after treated with boiling water, whereas the DR5-AP was thermal stable. The surface receptor of AsPC-1 and Capan-2 could be recognized and bound by AP-TRAIL after treated at 100 °C, the readings were 2. 210±0. 393 and 2. 027±0. 019.
CONCLUSION:
The TRAIL receptors are thermostable and this may provide a better diagnosis and prognosis of cancer as well as personalize cancer therapy.
AuthorsYang Xu, Hai-peng Liu, Tian-zhen Long, Guang-ping Luo, Peng Liang
JournalSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition (Sichuan Da Xue Xue Bao Yi Xue Ban) Vol. 46 Issue 3 Pg. 449-52 (May 2015) ISSN: 1672-173X [Print] China
PMID26121872 (Publication Type: Journal Article)
Chemical References
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Recombinant Proteins
Topics
  • Cell Line, Tumor
  • Hot Temperature
  • Humans
  • Pancreatic Neoplasms (metabolism)
  • Protein Stability
  • Receptors, TNF-Related Apoptosis-Inducing Ligand (metabolism)
  • Recombinant Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: